​

Werewolf Therapeutics Ownership | Who Owns Werewolf Therapeutics?


OverviewForecastRevenueFinancialsChart

Werewolf Therapeutics Ownership Summary


Werewolf Therapeutics is owned by 26.21% institutional investors, 6.63% insiders, and 67.16% retail investors. Ra capital management is the largest institutional shareholder, holding 14.52% of HOWL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.80% of its assets in Werewolf Therapeutics shares.

HOWL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockWerewolf Therapeutics26.21%6.63%67.16%
SectorHealthcare Stocks 129.28%12.06%-41.34%
IndustryBiotech Stocks 181.42%11.67%-93.09%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management6.68M14.52%$5.56M
Mpm asset management4.31M9.58%$8.49M
Bank of america corp /de/2.15M5.16%$5.24M
Blackrock1.59M3.82%$3.87M
Vanguard group1.41M3.10%$892.70K
Bioimpact capital1.21M2.63%$1.01M
Vanguard capital management1.22M2.51%$1.12M
Lynx1 capital management lp657.79K1.43%$547.67K
Sphera funds management626.81K1.36%$521.88K
Dc funds, lp589.10K1.21%$543.33K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Dc funds, lp589.10K73.28%$543.33K
Mpm asset management4.31M19.08%$8.49M
Lynx1 capital management lp657.79K0.09%$547.67K
Sphera funds management626.81K0.08%$521.88K
Covestor134.21K0.08%$124.00K
Bioimpact capital1.21M0.08%$1.01M
Pfm health sciences, lp401.11K0.06%$790.19K
Ra capital management6.68M0.06%$5.56M
Verdad advisers, lp29.76K0.03%$24.78K
Marest capital10.87K0.01%$10.03K

Top Buyers

HolderShares% AssetsChange
Blackrock1.59M0.00%1.42M
Hrt financial lp415.19K0.00%415.19K
Acadian asset management316.67K0.00%316.67K
Jane street group564.53K-312.69K
Bank of america corp /de/2.15M0.00%266.31K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp---2.00M
Rubric capital management lp---1.33M
Monashee investment management---890.00K
Eagle health investments lp---700.00K
Verition fund management---233.83K

New Positions

HolderShares% AssetsChangeValue
Acadian asset management316.67K0.00%316.67K$291.00K
Covestor134.21K0.08%134.21K$124.00K
Xtx topco50.93K0.00%50.93K$42.40K
Cubist systematic strategies46.71K0.00%46.71K$92.02K
Verdad advisers, lp29.76K0.03%29.76K$24.78K

Sold Out

HolderChange
Ifp advisors-1.00
Srs capital advisors-12.00
True wealth design-13.00
Eversource wealth advisors-35.00
Fmr-39.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202646-2.13%12,738,67817.25%265.24%2636.84%5-44.44%
Jun 30, 202647-2.08%10,864,466-22.40%222.69%19-9-25.00%
Mar 31, 202619-62.00%2,276,488-84.55%40.47%10-52.38%3-81.25%
Dec 31, 202531-50.00%3,199,424-84.84%70.32%15-28.57%9-50.00%
Sep 30, 202560-3.23%20,872,525-5.08%461.94%20-33.33%18-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv873.75K1.80%-
Vanguard Morn Total Stk Mkt Idx Investor873.75K1.80%-
Vanguard MStar Total Stk Mkt Idx Invest873.75K1.80%-
Vanguard US Total Market Shares ETF800.28K1.79%-
HBM Healthcare Investments AG Ord396.80K0.91%-60.51K
Vanguard Institutional Extnd Mkt Idx Tr344.23K0.71%-
Fidelity Small Cap Index311.53K0.69%-
A4Investments SICAV SIF ACCI IlanaA2EURH300.00K0.62%300.00K
BIT Biotech Opportunities S241.06K0.54%-
Abante Quant Value FI226.53K0.47%109.21K

Recent Insider Transactions


DateNameRoleActivityValue
Jul 07, 2026EVNIN LUKE-Sell$33.30K
Jul 06, 2026EVNIN LUKE-Sell$11.45K
Jun 29, 2026EVNIN LUKE-Sell$47.13K
Jun 17, 2026RA CAPITAL MANAGEMENT, L.P.-Sell$9.69K
Jun 17, 2026RA CAPITAL MANAGEMENT, L.P.-Sell$136.23K

Insider Transactions Trends


DateBuySell
2026 Q3-2
2026 Q2-50
2026 Q1-11
2025 Q4-100
2025 Q23-

HOWL Ownership FAQ


Who Owns Werewolf Therapeutics?

Werewolf Therapeutics shareholders are primarily institutional investors at 26.21%, followed by 6.63% insiders and 67.16% retail investors. The average institutional ownership in Werewolf Therapeutics's industry, Biotech Stocks , is 181.42%, which Werewolf Therapeutics falls below.

Who owns the most shares of Werewolf Therapeutics?

Werewolf Therapeutics’s largest shareholders are Ra capital management (6.68M shares, 14.52%), Mpm asset management (4.31M shares, 9.58%), and Bank of america corp /de/ (2.15M shares, 5.16%). Together, they hold 29.26% of Werewolf Therapeutics’s total shares outstanding.

Does Blackrock own Werewolf Therapeutics?

Yes, BlackRock owns 3.82% of Werewolf Therapeutics, totaling 1.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.87M$. In the last quarter, BlackRock increased its holdings by 1.42M shares, a 863.47% change.

Who is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested?

Dc funds, lp is Werewolf Therapeutics’s biggest shareholder by percentage of total assets invested, with 73.28% of its assets in 589.1K Werewolf Therapeutics shares, valued at 543.33K$.

Who is the top mutual fund holder of Werewolf Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Werewolf Therapeutics shares, with 1.80% of its total shares outstanding invested in 873.74K Werewolf Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools